Patent Assignment
Reel/Frame 017224/0910
Assignment of Assignor's Interest
Recorded: 2006-02-01
Pages: 10
Assignor
INTERMUNE, INC.
Executed: 2005-12-30
Assignee
VALEANT PHARMACEUTICALS NORTH AMERICA
3300 HYLAND AVENUE, COSTA MESA, CALIFORNIA, 92626
Covered Properties
(5)
Method for treating hepatitis c virus infection in treatment failure patients
Application:
10/490,456 →
Publication:
US 2005/0031585
Method of treating hepatitis virus infection with a multiphasic interferon delivery profile
Application:
10/490,458 →
Publication:
US 2005/0063949
Method for treating hepatitis c virus infection in treatment failure patients
Application:
10/490,503 →
Publication:
US 2005/0031586
Combination therapy for treating alphavirus infection and liver fibrosis
Application:
10/545,864 →
Publication:
US 2007/0072181
Compositions and methods for treating coronavirus infection and SARS
Application:
10/814,701 →
Publication:
US 2005/0002901
Related Assignments
(10)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest
Aug 20, 2004
From: BLATT, LAWRENCE M.
To: INTERMUNE, INC.
Reel/Frame 015016/0630 →
Assignment of Assignor's Interest
Aug 20, 2004
From: HSU, HENRY H.
To: INTERMUNE, INC.
Reel/Frame 015920/0814 →
Assignment of Assignor's Interest
Aug 20, 2004
From: HSU, HENRY H.
To: INTERMUNE, INC.
Reel/Frame 015920/0904 →
Assignment of Assignor's Interest
Sep 30, 2004
From: VISOR, GARY; VAN VLASSELAER, PETER
To: INTERMUNE, INC.
Reel/Frame 016040/0597 →
Corrective Assignment to Correct the Filing Date of Application Number 10490456 Previously Recorded on Reel 015920 Frame 0904. Assignor(S) Hereby Confirms the Correct Filing Date Is 08/20/2004.
Jul 20, 2005
From: HSU, HENRY H.
To: INTERMUNE, INC.
Reel/Frame 016287/0579 →
Assignment of Assignor's Interest
Jun 4, 2007
From: BLATT, LAWRENCE M.
To: INTERMUNE, INC.
Reel/Frame 019373/0588 →
Assignment of Assignor's Interest
Jan 14, 2008
From: VALEANT PHARMACEUTICALS NORTH AMERICA
To: THREE RIVERS PHARMACEUTICALS, LLC
Reel/Frame 020360/0234 →
Security Agreement
Jan 15, 2008
From: THREE RIVERS PHARMACEUTICALS, LLC; THREE RIVERS RESEARCH INSTITUTE 1, LLC; 3RP INVESTMENT CORPORATION; THREE RIVERS BIOLOGICS, LLC
To: NATIONAL CITY BANK
Reel/Frame 020362/0787 →
Release of Security Interest
Jul 15, 2010
From: PNC BANK, NATIONAL ASSOCIATION
To: THREE RIVERS PHARMACEUTICALS, LLC; THREE RIVERS RESEARCH INSTITUTE I, LLC; 3RP INVESTMENT CORPORATION; THREE RIVERS BIOLOGICS, LLC
Reel/Frame 024686/0764 →
Security Agreement
Nov 23, 2011
From: KADMON PHARMACEUTICALS, LLC
To: CORTLAND CAPITAL MARKET SERVICES LLC, AS ADMINISTRATIVE AGENT
Reel/Frame 027280/0954 →